Your monthly Qelbree cost savings if eligible
If you are eligible to receive your Qelbree prescription through the patient assistance program, your medication will be free. We charge a flat monthly service fee of $49 per medication to cover the cost of our services.
Am I eligible for Qelbree patient assistance?
To be eligible for the Qelbree patient assistance program, you will need to meet specific eligibility criteria set by the pharmaceutical company. At NiceRx, we review each Qelbree enrollment application individually. The main factors considered are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Qelbree patient assistance program?
Applying for the Qelbree patient assistance program through NiceRx is simple. Begin by completing the enrollment application on our website. We will ask for details about your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers that supply your medication. We may be able to help you access patient assistance for other medications as well as Qelbree, so please tell us about any medications that you have been prescribed.
If we determine that you may be eligible for Qelbree assistance, we will handle the full enrollment process on your behalf. We will work with your healthcare provider to prepare and submit all the documents required for you to enroll. If you are successfully enrolled in the Qelbree patient assistance program, we will also request your Qelbree medication refills on your behalf for up to 1 year. At the end of your enrollment period, we will contact you for updated details and seek to re-enroll you in the program.
Is NiceRx a Qelbree coupons provider?
NiceRx does not provide Qelbree coupons, discount cards, or copay cards. We do not offer printable Qelbree manufacturer coupons, Qelbree discounts, rebates, Qelbree savings cards, trial offers, or free samples. We are a service provider that helps eligible individuals access patient assistance programs. Our service cost is $49 a month per medication, so you will likely save more on your Qelbree medication with NiceRx.
Can NiceRx help me get Qelbree if I have insurance?
NiceRx may be able to help you access Qelbree patient assistance if:
- You have a high copay or coinsurance responsibility for Qelbree
- Your insurance company will not pay for your Qelbree prescription
- You do not have insurance
Complete your enrollment application online to find out more.
How much does Qelbree cost without insurance?
Qelbree prices without insurance will vary by retailer. As a guide, Qelbree oral capsule, extended-release 100 mg will typically cost around $322 for a supply of 30 capsules.
How much does Qelbree cost with insurance?
Your individual healthcare plan will determine the copay of Qelbree with insurance. To find out what you will need to pay, contact your pharmacist or insurance provider. They will be able to calculate your copay with your current insurance.
What is Qelbree?
Qelbree (viloxazine extended-release capsules) is an FDA-approved non-stimulant medication manufactured by Supernus Pharmaceuticals, Inc for adolescents between 6 to 17 years of age and indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD).
Qelbree met the goal of 3 different clinical trials – a significant reduction in ADHD symptom scores in 6 weeks. For some patients, Qelbree reduced ADHD symptom scores as early as week 1.
Qelbree is a selective norepinephrine reuptake inhibitor. It is presented as an extended-release capsule in various doses and is administered orally, with or without food.
The mechanism of action of Qelbree in the treatment of ADHD is unclear, however, it is thought to work by inhibiting the reuptake of norepinephrine.
Qelbree is a new non-controlled substance.
What doses of Qelbree are available?
Qelbree is available in extended-release capsule form, in the following doses: 100mg (yellow opaque body and cap containing 115mg of viloxazine hydrochloride salt), 150mg (lavender opaque body and cap containing 173mg of viloxazine hydrochloride salt), and 200mg (light green opaque body and cap containing 231mg of viloxazine hydrochloride salt).
For pediatric patients 6 to 11 years of age, the recommended starting dosage is 100 mg once daily. Patients may be titrated in increments of 100 mg weekly to the maximum recommended dosage of 400 mg once daily.
For pediatric patients 12 to 17 years of age: Recommended starting dosage is 200 mg once daily. May titrate after 1 week, by an increment of 200mg, to the maximum recommended dosage of 400 mg once daily.
In patients with severe renal impairment, the initial dosage is 100 mg once daily. Patients may be titrated in weekly increments of 50 mg to 100 mg to a maximum recommended dosage of 200 mg once daily.
Patients should swallow capsules whole or open the capsule and sprinkle the entire contents onto a teaspoon of applesauce.
Always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Qelbree active ingredients
Qelbree contains the active ingredient viloxazine.
Qelbree side effects
The most common side effects caused by Qelbree include:
- Tiredness and somnolence
- Decreased appetite
- Trouble sleeping
In rare instances, Qelbree can cause more serious side effects. These can include:
- Increased diastolic blood pressure and heart rate
- Manic episodes. Manic episodes may happen in people with bipolar disorder who take Qelbree. Symptoms may include greatly increased energy, racing thoughts, unusually grand ideas, talking more or faster than usual, severe trouble sleeping, reckless behavior, and excessive happiness or irritability
- Sleepiness and tiredness
Your doctor will assess the benefits of using Qelbree against your risk of side effects.
Qelbree has a black boxed warning: Suicidal thoughts and behaviors. In clinical trials, higher rates of suicidal thoughts and behavior were reported in pediatric patients treated with Qelbree than in patients treated with placebo. There should be close monitoring for worsening and emergence of suicidal thoughts and behaviors.
Patients are encouraged to report negative side effects or adverse reactions of Qelbree to the FDA (Food and drug administration). Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Qelbree drug interactions
Qelbree can interact with other medications. These include:
- MAOI (monoamine oxidase inhibitor) such as isocarboxazid, linezolid, methylene blue, moclobemide, phenelzine, procarbazine, rasagiline, safinamide, selegiline, tranylcypromine. Most MAOI should also not be taken for two weeks before and after treatment with Qelbree
This list is not exhaustive and other drugs may interact with Qelbree.
You should not use Qelbree if you:
- Are allergic to the active ingredient Qelbree
- Are allergic to any of the other ingredients in Qelbree
- Are pregnant or are planning to become pregnant
Talk to your doctor before using Qelbree if you:
- Are taking any of the medications that could interact with Qelbree such as concomitant administration of sensitive CYP1A2 substrates or CYP1A2 substrates with a narrow therapeutic range
- Are taking any of the medications that could interact with Qelbree such as concomitant administration of monoamine oxidase inhibitors (MAOI), or dosing within 14 days after discontinuing an MAOI
- Are breastfeeding or are planning to breastfeed
- Are taking herbal supplements
Qelbree is the trademark brand name for viloxazine manufactured by Supernus Pharmaceuticals, Inc. A generic version of Qelbree is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Qelbree savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.